DRREDDY.BO

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,276.40

Jun 02, 2026

AI Brief

Revenue · FY

$335.93B

Net income

$42.85B

FY 2026

EPS · diluted

$51.42

EBITDA

$67.05B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Insiders Sentiment ESG Options Disclosures

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1276.40

Change

+7.92%

Period high

$1336.95

Period low

$1182.35

Period start

$1182.752026-02-01

Through 2026-06-02

Fair value

Football field →

Weighted blend

$1,116.74

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Financial Services
+2.01%
Real Estate
+1.34%
Healthcare
+0.90%
Industrials
+0.55%
Utilities
+0.48%
Consumer Defensive
+0.44%
Consumer Cyclical
+0.15%
Energy
-0.16%
Technology
-1.03%
Communication Services
-1.11%
Basic Materials
-1.15%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.72%
Silver
-5.21%
Other Precious Metals
-4.97%
Copper
-3.47%
Gold
-3.27%
Medical - Healthcare Information Services
-3.26%
Information Technology Services
-2.74%
Software - Infrastructure
-2.53%
Insurance - Reinsurance
+2.14%
Coal
-2.14%
REIT - Healthcare Facilities
+2.12%
Electronic Gaming & Multimedia
-2.09%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DRREDDY.BO.

Peers

No peer list available for DRREDDY.BO.

Total assets

$579.35B

Total debt

$77.34B

Cash & equiv

$15.37B

Operating CF

$53.84B

Free cash flow

$30.51B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$335.93B	$46.44B	$42.85B	$51.42	+12.76%